Sandoz International GmbH - Strategy, SWOT and Corporate Finance Report
Summary
Sandoz International GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Sandoz International GmbH (Sandoz or ‘the company’), a subsidiary of Novartis AG, is engaged in the development, testing, manufacturing, commercialization, and marketing of prescription medicines, as well as pharmaceutical active ingredients. The company provides biosimilars, generic antibiotics, dermatology, and transplantation medicines. Its biosimilars comprise Omnitrope, Binocrit and Zarzio products. Sandoz has expertise in the areas of generic cardiovascular, central nervous system (CNS), pain and ophthalmology, respiratory and hormonal therapeutics. The company sells its products through a network of distributors in Germany and abroad. Sandoz’s business operations are spread across the US, Europe, Asia, Africa, Australasia, Canada, and Latin America. The company is headquartered in Holzkirchen, Germany.
Scope
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook